View in EDS PDF Full Text

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.

Saved in:
Bibliographic Details
Title: HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Authors: Bièche I; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France.; INSERM U1016, Institut Cochin, Paris, France., Coussy F; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., El-Botty R; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Vacher S; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France., Château-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France., Dahmani A; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Montaudon E; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Reyes C; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Gentien D; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France., Reyal F; Surgery Department, Institut Curie, PSL Research University, Paris, France.; INSERM U932, Immunity and Cancer, Institut Curie, Paris, France., Ricci F; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France., Nicolas A; Pathex, Institut Curie, PSL Research University, Paris, France., Marchio C; Institut Curie, Pathology Department, PSL Research University, Paris, France.; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Turin, Turin, Italy., Vincent-Salomon A; Institut Curie, Pathology Department, PSL Research University, Paris, France., Laé M; Pathology Department, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen, France., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France. elisabetta.marangoni@curie.fr.
Source: Journal of hematology & oncology [J Hematol Oncol] 2021 Sep 08; Vol. 14 (1), pp. 143. Date of Electronic Publication: 2021 Sep 08.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34496925
AccessLevel: 2
PubType: Report
PubTypeId: report
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bièche+I%22">Bièche I</searchLink>; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France.; INSERM U1016, Institut Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Coussy+F%22">Coussy F</searchLink>; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22El-Botty+R%22">El-Botty R</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vacher+S%22">Vacher S</searchLink>; Genetics Department, Institut Curie, University of Paris, Paris, France.; Department of Diagnostic and Theranostic Medicine Paris, University of Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Château-Joubert+S%22">Château-Joubert S</searchLink>; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons Alfort, France.<br /><searchLink fieldCode="AU" term="%22Dahmani+A%22">Dahmani A</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Montaudon+E%22">Montaudon E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyes+C%22">Reyes C</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gentien+D%22">Gentien D</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Surgery Department, Institut Curie, PSL Research University, Paris, France.; INSERM U932, Immunity and Cancer, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ricci+F%22">Ricci F</searchLink>; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+A%22">Nicolas A</searchLink>; Pathex, Institut Curie, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Marchio+C%22">Marchio C</searchLink>; Institut Curie, Pathology Department, PSL Research University, Paris, France.; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Vincent-Salomon+A%22">Vincent-Salomon A</searchLink>; Institut Curie, Pathology Department, PSL Research University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Laé+M%22">Laé M</searchLink>; Pathology Department, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 26 Rue d'Ulm, 75005, Paris, France. elisabetta.marangoni@curie.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2021 Sep 08; Vol. 14 (1), pp. 143. <i>Date of Electronic Publication: </i>2021 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34496925
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13045-021-01158-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 143
    Titles:
      – TitleFull: HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bièche I
      – PersonEntity:
          Name:
            NameFull: Coussy F
      – PersonEntity:
          Name:
            NameFull: El-Botty R
      – PersonEntity:
          Name:
            NameFull: Vacher S
      – PersonEntity:
          Name:
            NameFull: Château-Joubert S
      – PersonEntity:
          Name:
            NameFull: Dahmani A
      – PersonEntity:
          Name:
            NameFull: Montaudon E
      – PersonEntity:
          Name:
            NameFull: Reyes C
      – PersonEntity:
          Name:
            NameFull: Gentien D
      – PersonEntity:
          Name:
            NameFull: Reyal F
      – PersonEntity:
          Name:
            NameFull: Ricci F
      – PersonEntity:
          Name:
            NameFull: Nicolas A
      – PersonEntity:
          Name:
            NameFull: Marchio C
      – PersonEntity:
          Name:
            NameFull: Vincent-Salomon A
      – PersonEntity:
          Name:
            NameFull: Laé M
      – PersonEntity:
          Name:
            NameFull: Marangoni E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 09
              Text: 2021 Sep 08
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1756-8722
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of hematology & oncology
              Type: main
ResultId 1